Gene therapy of chondrosarcoma using retrovirus vectors encoding the herpes simplex virus thymidine kinase gene

Int J Oncol. 1999 Jun;14(6):1137-41. doi: 10.3892/ijo.14.6.1137.

Abstract

Human chondrosarcoma cells (HCS-TG) were transduced with the gene for a herpes simplex virus thymidine kinase (HSV-tk) or Escherichia coli beta-galactosidase (lacZ). We investigated the cytotoxicity of human chondrosarcoma bearing an HSV-tk gene after treatment with ganciclovir. Chondrosarcoma cells bearing an HSV-tk gene were more sensitive than non-transduced cells. Coculturing with chondrosarcoma cells bearing both an HSV-tk gene (HCS-TG-tk) and lacZ gene (HCS-TG-Z) in various ratios showed a bystander effect. Chondrosarcoma implanted in nude mice were injected with HCS-TG-tk cells. After 4 weeks, the growth of tumors was significantly prevented.

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Avian Sarcoma Viruses / genetics*
  • Bone Neoplasms / enzymology
  • Bone Neoplasms / genetics
  • Bone Neoplasms / pathology
  • Bone Neoplasms / therapy*
  • Cell Division / drug effects
  • Chondrosarcoma / enzymology
  • Chondrosarcoma / genetics
  • Chondrosarcoma / pathology
  • Chondrosarcoma / therapy*
  • Coculture Techniques
  • Dose-Response Relationship, Drug
  • Escherichia coli / enzymology
  • Escherichia coli / genetics
  • Ganciclovir / pharmacology
  • Genetic Therapy / methods*
  • Genetic Vectors
  • Humans
  • Male
  • Mice
  • Mice, Inbred ICR
  • Mice, Nude
  • Moloney murine leukemia virus / genetics*
  • Neoplasm Transplantation
  • Simplexvirus / enzymology*
  • Thymidine Kinase / genetics*
  • Transfection
  • Tumor Cells, Cultured
  • beta-Galactosidase / genetics

Substances

  • Antiviral Agents
  • Thymidine Kinase
  • beta-Galactosidase
  • Ganciclovir